![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA, EMA to Hold ‘One-on-One’ Talks on Orphan Drugs With Industry
FDA, EMA to Hold ‘One-on-One’ Talks on Orphan Drugs With Industry
August 23, 2013
The FDA and the European Medicines Agency (EMA) will hold a joint workshop this fall for drug- and devicemakers of orphan products to discuss both agencies’ rare disease programs. In addition to overview sessions on programs from both regulators, manufacturers will have the opportunity Oct. 4 to register for one-on-one meetings with FDA staff or EMA staff via video teleconference, to discuss specifics on applying for an orphan product grant or designation.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
21Oct